Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ADUSNYSE:AGLNASDAQ:FTRENASDAQ:PGNY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADUSAddus HomeCare$111.86+1.4%$111.13$88.96▼$136.72$2.03B0.81166,108 shs91,160 shsAGLAgilon Health$2.40+0.3%$2.66$1.50▼$7.73$989.34M0.164.80 million shs2.54 million shsFTREFortrea$5.23+1.1%$5.20$3.97▼$28.41$467.89M1.761.94 million shs837,673 shsPGNYProgyny$21.45+1.0%$21.83$13.39▼$30.42$1.82B1.311.71 million shs605,548 shs7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADUSAddus HomeCare-2.28%-2.69%-0.75%+8.92%-5.38%AGLAgilon Health-0.42%+8.68%+5.54%-40.43%-59.56%FTREFortrea-0.77%-0.19%+25.18%-23.86%-78.28%PGNYProgyny-3.72%+1.58%-2.12%-8.25%-25.03%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationADUSAddus HomeCare4.9679 of 5 stars3.65.00.05.02.02.53.1AGLAgilon Health2.2812 of 5 stars4.11.00.00.02.50.00.6FTREFortrea4.0218 of 5 stars3.91.00.00.02.80.83.8PGNYProgyny1.0977 of 5 stars1.22.00.00.01.82.51.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADUSAddus HomeCare 3.25Buy$142.5727.46% UpsideAGLAgilon Health 2.17Hold$4.7999.74% UpsideFTREFortrea 1.86Reduce$15.00187.08% UpsidePGNYProgyny 2.42Hold$23.459.35% UpsideCurrent Analyst Ratings BreakdownLatest FTRE, PGNY, ADUS, and AGL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/20/2025ADUSAddus HomeCareJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$150.006/10/2025ADUSAddus HomeCareMacquarieSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$133.005/22/2025FTREFortreaCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral5/14/2025FTREFortreaCowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold5/14/2025FTREFortreaMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$10.00 ➝ $8.005/14/2025FTREFortreaThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$7.00 ➝ $5.005/13/2025AGLAgilon HealthWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$6.00 ➝ $5.005/13/2025FTREFortreaBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetUnderweight ➝ Underweight$6.00 ➝ $5.005/12/2025PGNYProgynyCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$23.00 ➝ $21.005/8/2025ADUSAddus HomeCareMacquarieSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$129.00 ➝ $133.005/8/2025AGLAgilon HealthBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetUnderweight ➝ Underweight$2.00 ➝ $3.00(Data available from 7/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADUSAddus HomeCare$1.15B1.78$5.46 per share20.48$53.52 per share2.09AGLAgilon Health$6.06B0.16N/AN/A$1.14 per share2.10FTREFortrea$2.70B0.18$1.59 per share3.29$15.19 per share0.34PGNYProgyny$1.17B1.58$0.35 per share61.55$4.96 per share4.32Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADUSAddus HomeCare$73.60M$4.4325.2520.871.566.52%9.23%6.96%8/4/2025 (Estimated)AGLAgilon Health-$260.15M-$0.590.00N/AN/A-4.04%-45.47%-12.76%8/5/2025 (Estimated)FTREFortrea-$328.50M-$8.7912.934.080.35-29.43%2.84%1.06%8/11/2025 (Estimated)PGNYProgyny$54.34M$0.5737.6333.002.234.33%10.90%7.20%8/5/2025 (Estimated)Latest FTRE, PGNY, ADUS, and AGL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/12/2025Q1 2025FTREFortrea-$0.07$0.02+$0.09-$6.25$609.63 million$651.30 million5/8/2025Q1 2025PGNYProgyny$0.45$0.17-$0.28$0.17$307.86 million$324.04 million5/6/2025Q1 2025AGLAgilon Health-$0.01$0.03+$0.04$0.03$1.50 billion$1.53 billion5/5/2025Q1 2025ADUSAddus HomeCare$1.33$1.42+$0.09$1.16$341.66 million$337.71 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthADUSAddus HomeCareN/AN/AN/AN/AN/AAGLAgilon HealthN/AN/AN/AN/AN/AFTREFortreaN/AN/AN/AN/AN/APGNYProgynyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioADUSAddus HomeCare0.201.741.74AGLAgilon HealthN/A1.201.20FTREFortrea1.220.970.97PGNYProgynyN/A2.392.39Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipADUSAddus HomeCare95.35%AGLAgilon HealthN/AFTREFortreaN/APGNYProgyny94.93%Insider OwnershipCompanyInsider OwnershipADUSAddus HomeCare4.60%AGLAgilon Health3.57%FTREFortrea0.38%PGNYProgyny9.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableADUSAddus HomeCare49,70318.40 million17.55 millionOptionableAGLAgilon Health1,076413.95 million399.17 millionNot OptionableFTREFortrea15,50090.50 million90.16 millionOptionablePGNYProgyny31085.72 million77.66 millionOptionableFTRE, PGNY, ADUS, and AGL HeadlinesRecent News About These CompaniesProgyny’s Q1 Earnings Call: Our Top 5 Analyst QuestionsJuly 1 at 11:44 AM | msn.comAnalysts Set Progyny, Inc. (NASDAQ:PGNY) PT at $23.45July 1 at 2:21 AM | americanbankingnews.comProgyny, Inc. (PGNY) stock price, news, quote & history - Yahoo FinanceJune 30 at 8:41 PM | nz.finance.yahoo.comProgyny, Inc. (PGNY) - Yahoo FinanceJune 29, 2025 | finance.yahoo.comProgyny, Inc. (NASDAQ:PGNY) Receives Average Rating of "Hold" from AnalystsJune 28, 2025 | marketbeat.comProgyny Expands Women's Health Offerings with New Pelvic Floor Therapy Services - NasdaqJune 26, 2025 | nasdaq.comProgyny Adds Pelvic Floor Therapy, Continuing to Close Gaps in Care Across Women’s HealthJune 24, 2025 | finance.yahoo.comHinge Health joins Progyny for pelvic floor therapyJune 24, 2025 | msn.comProgyny Adds Pelvic Floor Therapy, Continuing to Close Gaps in Care Across Women's HealthJune 24, 2025 | globenewswire.comProgyny Earns Relative Strength Rating UpgradeJune 23, 2025 | msn.comProgyny (PGNY) Soared on Expanding Client Base and Improving Utilization TrendsJune 18, 2025 | msn.comFort Washington Investment Advisors Inc. OH Reduces Stake in Progyny, Inc. (NASDAQ:PGNY)June 13, 2025 | marketbeat.comGAMMA Investing LLC Acquires 118,556 Shares of Progyny, Inc. (NASDAQ:PGNY)June 13, 2025 | marketbeat.comCheryl Scott Sells 2,675 Shares of Progyny, Inc. (NASDAQ:PGNY) StockJune 12, 2025 | marketbeat.comProgyny Stock Trades Higher On Collaboration With Amazon’s Health Benefits Connector: Retail’s Yet To Be ImpressedJune 10, 2025 | msn.comProgyny Joins Amazon’s Health Benefits Connector Program as First Women’s Health and Family Building SolutionJune 10, 2025 | finance.yahoo.comProgyny Joins Amazon's Health Benefits Connector Program as First Women's Health and Family Building SolutionJune 10, 2025 | globenewswire.comHere’s Why Progyny (PGNY) Rebounded in Q1June 9, 2025 | msn.comOlstein Capital Management L.P. Buys New Shares in Progyny, Inc. (NASDAQ:PGNY)June 9, 2025 | marketbeat.comProgyny, Inc. (NASDAQ:PGNY) Shares Acquired by NBC Securities Inc.June 6, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Lowers Stock Position in Progyny, Inc. (NASDAQ:PGNY)June 5, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeFTRE, PGNY, ADUS, and AGL Company DescriptionsAddus HomeCare NASDAQ:ADUS$111.86 +1.49 (+1.35%) Closing price 03:55 PM EasternExtended Trading$111.86 0.00 (0.00%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.Agilon Health NYSE:AGL$2.40 +0.01 (+0.25%) Closing price 03:57 PM EasternExtended Trading$2.40 +0.00 (+0.13%) As of 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.Fortrea NASDAQ:FTRE$5.22 +0.06 (+1.06%) Closing price 03:44 PM EasternExtended Trading$5.22 0.00 (0.00%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.Progyny NASDAQ:PGNY$21.45 +0.21 (+0.99%) Closing price 01:23 PM EasternExtended Trading$21.16 -0.29 (-1.33%) As of 04:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Rocket Lab: Latest Catalysts Bolster the Bull Case Nike's Stock Just Got an Upgrade: Is a Real Comeback Brewing? Why Hims & Hers Is a Buy Below $35 After Its 16% Pullback Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
